"A Debreceni Egyetemen a betegellátási tevékenység magas színvonalú megvalósítását a Klinikai Központ biztosítja. Hazánk egyik legnagyobb egészségügyi szolgáltatójaként két Campuson (Nagyerdei és Kenézy Gyula Campusok) széleskörű, a progresszivitás legmagasabb szintjét képviselő diagnosztikai, betegellátó és ehhez kapcsolódó oktató és kutató tevékenységet folytatunk. A Debreceni Egyetem Klinikai Központja több mint 6000 dolgozóval, köztük 1544 orvossal, 4073 egészségügyi szakdolgozóval szolgálja a betegek gyógyulását."

During the past decade, Debreceni Egyetem Klinikai Kozpont conducted 199 clinical trials. In the 10-year time frame, 199 clinical trials started and 117 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 88 clinical trials were completed. i.e. 89.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Debreceni Egyetem Klinikai Kozpont" #1 sponsor was "Pfizer" with 32 trials, followed by "Janssen Research & Development, LLC" with 16 trials sponsored, "Bayer" with 15 trials sponsored, "Amgen" with 14 trials sponsored and "Boehringer Ingelheim" with 14 trials sponsored. Other sponsors include 155 different institutions and companies that sponsored additional 97 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem Klinikai Kozpont" #1 collaborator was "Eli Lilly and Company" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Takeda Development Center Americas, Inc." with 3 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem Klinikai Kozpont" are "Ulcerative Colitis" (16 trials), "Crohn's Disease" (12 trials), "Psoriasis" (7 trials), "Systemic Lupus Erythematosus" (7 trials) and "Diabetes Mellitus, Type 2" (6 trials). Many other conditions were trialed in "Debreceni Egyetem Klinikai Kozpont" in a lesser frequency.

Most popular intervention types in "Debreceni Egyetem Klinikai Kozpont" are "Drug" (230 trials), "Other" (28 trials), "Biological" (17 trials), "Combination Product" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (92 trials), "BMS-986165" (7 trials), "Gemcitabine" (7 trials), "Rituximab" (7 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Debreceni Egyetem Klinikai Kozpont" are 233 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Debreceni Egyetem Klinikai Kozpont". undefined are not yet recruiting, 45 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 127 completed trials in Debreceni Egyetem Klinikai Kozpont, 1 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Debreceni Egyetem Klinikai Kozpont, 12 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 159 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 2 trials that are defined as “Not Applicable".